Trial Profile
Open-label randomized comparative study of cefepime vs. meropenem in adults with moderate to severe aspiration pneumonia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Sep 2021
Price :
$35
*
At a glance
- Drugs Cefepime (Primary) ; Meropenem (Primary) ; Azithromycin; Erythromycin
- Indications Aspiration pneumonia; Bacterial infections
- Focus Therapeutic Use
- 12 Sep 2021 Status changed from active, no longer recruiting to completed.
- 02 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 04 Mar 2013 Planned End Date changed from 1 Aug 2011 to 30 Oct 2013 as reported by University Hospital Medical Information Network - Japan.